Vanguard Global Advisers’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$112K Buy
58,153
+781
+1% +$2.2K ﹤0.01% 2721
2026
Q2
$178K Buy
57,372
+21,621
+60% +$71.1K ﹤0.01% 2549
2026
Q1
$96.2K Hold
35,751
– – ﹤0.01% 2746

Other funds holding CABA

Vanguard Global Advisers's CABA Position: Q3 2026 in Review

Vanguard Global Advisers increased its Cabaletta Bio (CABA) stake by 1.4% in Q3 2026, buying an estimated $2.2K and bringing the position to 58,153 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

Vanguard Global Advisers first reported a position in CABA in Q1 2026 and has held it in 3 quarters since. The position peaked at $178K in Q2 2026. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • Vanguard Global Advisers held 58,153 shares of Cabaletta Bio worth $112K as of Q3 2026.
  • Vanguard Global Advisers bought 781 Cabaletta Bio shares in Q3 2026, an estimated $2.2K.
  • Cabaletta Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2721 holding.
  • Vanguard Global Advisers first reported a position in Cabaletta Bio in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Cabaletta Bio position peaked at $178K in Q2 2026.
  • 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.